All sources, graded

High-dose omega-3 (EPA) lowers cardiovascular risk in high-risk patients.

Transparent rubric — every item shows its grade and computed weight. RCT > cohort > case > preclinical > opinion; predatory sources are knocked down 90%.

Weight = grade weight × log₁₀(sample size + 10). So a stronger study grade dominates, a bigger trial counts for a bit more, and predatory sources are cut to 10%. It is the exact number the score is built from — nothing hidden.

SideStudy gradeSort byHide predatory sources

Showing 3 of 3 sources.

rct · n=13,000Randomized trial

Randomized trial with a different formulation showed no cardiovascular benefit.

Source: Mixed-formulation RCT

contradicts · weight 16.46 · Randomized trial

rct · n=8,179Randomized trial

Randomized trial showed reduced cardiovascular events at high-dose purified EPA.

Source: REDUCE-IT-type trial

supports · weight 15.65 · Randomized trial

cohort · n=42,000Cohort study

Cohort: higher omega-3 intake associated with fewer events.

Source: Dietary cohort

supports · weight 13.87 · Cohort study